Eran Harary

Eran Harary, MD, is the Chief Medical Officer for Remepy. Dr. Harary joins Remepy from Teva Pharmaceuticals, where he held several senior leadership roles, including Senior Vice President and Global Head of Specialty R&D, overseeing programs in neuroscience, immunology, and other specialty areas, and, most recently, Senior Vice President and Global Head of Early Clinical Development. Earlier in his tenure at Teva, he led the Neurology and Psychiatry therapeutic area. With more than two decades of experience across the full drug development lifecycle, Dr. Harary has contributed to numerous programs from concept through approval and post-approval. Among them, he led UZEDY® (TV-46000) through approval, played a pivotal role in advancing Teva’s long-acting injectable programs, including olanzapine LAI, contributed to the development of AUSTEDO®, and helped secure and advance promising therapies in movement disorders and immunology. He was also instrumental in shaping Teva’s R&D strategy for AI, machine learning, big data, and emerging technologies. Earlier in his career, Dr. Harary held senior roles at Lundbeck, Pfizer, and Alcobra Pharma. He is a certified psychiatrist and earned his MD from Tel Aviv University’s School of Medicine.